Allena Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -4.79 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
1.17 | 4.82 | -75.73% |
|
|
| P/FCF |
|
-0.2749 | 61 | -100.45% |
|
|
| Ev/Ebitda |
|
0.2491 | -22.15 | -101.12% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
0.1263 | 68.78 | -99.82% |
|
|
| E/P |
|
-2.04 | 0.0178 | -11577.64% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | 0 | 0% |
| ROE |
|
-243.13 | 9.61 | -2629.59% |
|
|
| ROA |
|
-104.57 | 0.3443 | -30475.15% |
|
|
| ROIC |
|
-191.76 | 7.63 | -2611.8% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-343.73 | 15.35 | -2339.24% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0153 | -3.68 | -99.58% | -0.0153 | -0.5744% |
| Nеt Debt/Ebitda |
|
0.249 | -3.44 | -107.25% |
|
|
| Debt/Ratio |
|
0.0213 | 0.1985 | -89.24% |
|
|
| Debt/Equity |
|
0.3167 | 1.66 | -80.95% |
|
|
| Debt/Net Income |
|
-0.0138 | 10.32 | -100.13% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
-29.86 | -54.68 | -45.39% | ||
| Growth impulse Net Income in 5 years |
|
-22.75 | -58.33 | -61% | ||
| Growth impulse FCF in 5 years |
|
52.48 | -49.48 | -206.06% | ||
| Growth impulse EPS in 5 years |
|
-84.12 | -32.41 | 159.55% |
IP Score
3.26/10
